Gastrointestinal bleeding risk with rivaroxaban vs aspirin in atrial fibrillation: A multinational study

Gastrointestinal bleeding risk with rivaroxaban vs aspirin in atrial fibrillation: A multinational study

© 2020 The Authors. Pharmacoepidemiology and Drug Safety published by John Wiley & Sons Ltd. Purpose: Comparative gastrointestinal bleeding (GIB) risk between rivaroxaban and low-dose aspirin is unknown in patients with atrial fibrillation (AF). This study investigated GIB risk with rivaroxaba...

Full description

Saved in:
Bibliographic Details
Main Authors: Laura Fanning, Ian C.K. Wong, Xue Li, Esther W. Chan, Pajaree Mongkhon, Kenneth K.C. Man, Li Wei, Wai K. Leung, Peteris Darzins, Simon Bell, Jenni Ilomaki, Wallis C.Y. Lau
Format: Journal
Published: 2020
Subjects:
Medicine
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85090958669&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/70971
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University

Internet

https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85090958669&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/70971

Similar Items